European Journal of Immunology · 2011 · 86 citations · 19 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyCytokines In Tumor ImmunityImmune Evasion In CancerT Cell Responses To TumorsTumor-associated MacrophagesAntitumor Cytokine ResponsesCancer-associated ImmunosuppressionCancer-associated MacrophagesImmuno-oncology ModelsImmunosuppressive CompoundsImmunosuppressive FunctionTumor Incidence AnalysisTumor-host Immune Interactions
The L-phenylalanine oxidase IL4I1 inhibits T-cell proliferation in vitro through H(2) O(2) production, and is highly expressed in tumor-associated macrophages. IL4I1 is also detected by immunohistochemistry in neoplastic cells from several B-cell lymphomas and some non-lymphoid tumors. To evaluate IL4I1's effect on tumor growth, we developed a mouse melanoma model constitutively coexpressing IL4I1 and the GP33 epitope. After GP33 vaccination, tumors developed more frequently in mice injected with IL4I1-expressing cells in comparison with mice receiving control cells. Tumor escape was preceded by a rapid diminution of IFN-γ-producing cytotoxic antitumor CD8(+) T cells. Moreover, tumor incidence was already increased when only 20% of the injected cells expressed IL4I1. The minimal IL4I1 activities leading to tumor escape were close to those detected in human melanoma and mesothelioma. Thus, we demonstrate the immunosuppressive functions of IL4I1 in vivo and suggest that IL4I1 facilitates human tumor growth by inhibiting the CD8(+) antitumor T-cell response.
19
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak, Nicholas Bertos, François Pépin et al. · Nature Medicine · 2008 · 1.7K citations
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
David H. Munn, Ebrahim Shafizadeh, John T. Attwood et al. · The Journal of Experimental Medicine · 1999 · 1.6K citations · Full text